Catalent Partners with ViralClear Pharmaceuticals on Potential Treatment for COVID-19
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs,...
Calypso Biotech Completes CALY-002 Clinical Batch Manufacturing
AGC Biologics, a global biopharmaceutical Contract Development Manufacturing Organization (CDMO), produces a GMP-grade clinical batch...
Cobra signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate
Cobra Biologics, part of the Cognate BioServices family, an international CDMO for biologics and pharmaceuticals,...
Neurocrine and Takeda Ink $2 Billion-Plus Neuroscience Development Deal
San Diego-based Neurocrine Biosciences is partnering with Japan’s Takeda Pharmaceutical to develop and commercialize molecules...
Saiba AG Selects AGC Biologics to Develop and Produce COVID-19 Vaccine
AGC Biologics, a global biopharmaceutical Contract Development Manufacturing Organization (CDMO), has announced it will be...
Catalent Signs Agreement with AstraZeneca to Manufacture COVID-19 Vaccine Candidate
Catalent, Inc. , the leading global provider of advanced delivery technologies, development, and manufacturing solutions...
Fujifilm to invest 100 billion yen to expand its large scale biologics production facility...
FUJIFILM Corporation will make a major capital investment of approximately 100 billion yen (928 million...
The University of Queensland, CEPI and CSL partner to advance development and manufacture of...
CEPI, the Coalition for Epidemic Preparedness Innovations, CSL and The University of Queensland announced that...
Airway Therapeutics and Celonic Group Collaborate to Produce AT-100 as Promising New Candidate for...
Airway Therapeutics, Inc., a biopharmaceutical company developing a new class of biologics to break the...
Merck and Ridgeback Bio Collaborate to Advance Development of Novel Antiviral Candidate, EIDD-2801
Merck, known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics LP, a...
